Effects of Single Sodium Bicarbonate Supplementation on National-Level Finswimming Performance
Evaluation of the Effects of Single Sodium Bicarbonate Supplementation on Finswimming Performance of National Level Finswimmers: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
1 other identifier
interventional
20
1 country
1
Brief Summary
This randomized, double-blind, placebo-controlled crossover trial will investigate the acute effects of sodium bicarbonate supplementation on performance, stroke biomechanics, and selected physiological and perceptual responses during a simulated 200-meter Bi-Fins race in elite finswimmers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 17, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2026
ExpectedAugust 22, 2025
August 1, 2025
2 months
August 1, 2025
August 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Stroke rate (SR; cycles/min)
Calculated from video analysis to determine the number of stroke cycles per minute.
Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.
Total race time (seconds)
Total time to complete the 200-meter Bi-Fins time trial, measured using an electronic timing system. Lower values indicate better performance.
Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.
Stroke length (SL; meters/cycle)
Calculated from video analysis to determine the average distance traveled per stroke cycle.
Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.
Secondary Outcomes (10)
Underwater distance (meters)
Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.
Blood lactate concentration (mmol/L)
Baseline (10 minutes before warm-up) and 3 minutes post-exercise on each testing day
Actual base excess (ABE; mmol/L)
Baseline (10 minutes before warm-up), 10 minutes after warm-up, 5 minutes before race start, and 3 minutes post-exercise on each testing day
Blood bicarbonate concentration (HCO₃-; mmol/L)
Baseline (10 minutes before warm-up), 10 minutes after warm-up, 5 minutes before race start, and 3 minutes post-exercise on each testing day
Rate of Perceived Exertion (RPE; score on Borg Category Ratio 1-10 scale)
Immediately post-exercise on each testing day
- +5 more secondary outcomes
Study Arms (2)
Placebo Comparator
PLACEBO COMPARATORPlacebo: Food-grade starch Participants will ingest 300 mg·kg-¹ body mass of food-grade starch encapsulated in gelatin capsules 60-90 minutes prior to the simulated 200 m Bi-Fins race. Dietary Supplement: Placebo Gelatin capsules filled with food-grade starch, indistinguishable in appearance from sodium bicarbonate capsules. Water is consumed ad libitum during ingestion. Other Names: Placebo Capsules
Sodium Bicarbonate (NaHCO₃)
EXPERIMENTALSodium Bicarbonate: NaHCO₃ Participants will ingest 300 mg·kg-¹ body mass of sodium bicarbonate encapsulated in gelatin capsules 60-90 minutes prior to the simulated 200 m Bi-Fins race. Dietary Supplement: Sodium Bicarbonate Gelatin capsules containing sodium bicarbonate (NaHCO₃), matched in appearance, weight, and texture to placebo. Water is consumed ad libitum during ingestion. Other Names: NaHCO₃ Capsules
Interventions
Gelatin capsules each containing 1g sodium bicarbonate (NaHCO₃)
Eligibility Criteria
You may qualify if:
- Member of a wider national selection in finswimming (junior or senior level)
- Regular participation in competitive finswimming training (≥4 sessions per week)
- Age between 15 and 30 years
- Absence of chronic illness or injury
- No use of medications or dietary supplements during the study period
- Signed informed consent (for minors, also signed by a legal guardian)
You may not qualify if:
- History of gastrointestinal disorders affecting supplement tolerance
- Presence of cardiovascular, metabolic, or musculoskeletal disorders
- Current illness or acute infection
- Regular use of substances that may interfere with acid-base balance
- Refusal to comply with pre-test restrictions (e.g., 48 hours without training)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Palacký University, Faculty of Physical Culture
Olomouc, Olomoucký kraj, 77900, Czechia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tomáš Michalica, Mgr.
Palacký University, Faculty of Physical Culture
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Doctoral Researcher and Assistant Lecturer, Faculty of Physical Culture, Palacký University Olomouc
Study Record Dates
First Submitted
August 1, 2025
First Posted
August 22, 2025
Study Start
July 1, 2025
Primary Completion
August 17, 2025
Study Completion (Estimated)
December 20, 2026
Last Updated
August 22, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning 1 year after the publication of results with no end date.
All IPD that underlie results in a publication.